SAPHO syndrome;Le syndrome SAPHO

Revue de Medecine Interne

Volumn 35, Issue 9, 2014, Pages 595-600

  Gharsallah, I ^a   Souissi, A ^a   Dhahri, R ^a   Boussetta, N ^a   Sayeh, S ^a   Metoui L ^a   Ajili, F ^a   Louzir, B ^a   Othmani, S ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

Acne; Pustulosis; SAPHO; Spondyloarthropathies

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

DIAGNOSTIC TEST; DISEASE ASSOCIATION; HUMAN; OSTEOARTHROPATHY; SAPHO SYNDROME; SHORT SURVEY; SKIN MANIFESTATION; SPONDYLARTHRITIS; TREATMENT INDICATION; ACQUIRED HYPEROSTOSIS SYNDROME; DISEASE COURSE; PROGNOSIS;

ACQUIRED HYPEROSTOSIS SYNDROME; DISEASE PROGRESSION; HUMANS; PROGNOSIS;

EID: 84905403029     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2013.12.018     Document Type: Short Survey

References (53)

1. Windom R.E., Sanford J.P., Ziff M. Acne conglobata and arthritis. Arthritis Rheum 1961, 4:632-635.
2. Sasaki S. Arthralgia. Shinkei Kenkyu No Shimpo 1967, 11:122-128.
3. Bookbinder S.A., Fenske N.A., Clement G.B., Espinoza L.R., Germain B.F., Vasey F.B. Clavicular hyperostosis and acne arthritis. Ann Intern Med 1982, 4:615-616.
4. Chamot A.M., Benhamou C.L., Kahn M.F., Beraneck L., Kaplan G., Prost A. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85cases. Rev Rhum Osteoartic 1987, 3:187-196.
5. Kahn M.F., Kahn M.A. The SAPHO syndrome. Clin Rheum 1994, 8:333-362.
6. Benhamou C.L., Chamot A.M., Kahn M.F. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol 1988, 6:109-112.
7. Govoni M., Colina M., Massara A., Trotta F. SAPHO syndrome and infections. Autoimmunity 2009, 8:256-259.
8. Sampelean D., Adam M., Muntean V., Hanescu B., Domsa I. Pancreatic hamartoma and SAPHO syndrome: a case report. J Gastrointestin Liver Dis 2009, 18:483-486.
9. Assmann G., Kueck O., Kirchhoff T., Rosenthal H., Vaswinkeml J., Pfreundschuh M., et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: interventional study. Arthritis Res Ther 2009, 11:R140.
10. Wagner A.D., Mai U., Hammer M., Zeider H. Long-term antibiotic therapy in patients with SAPHO. Arthritis Rheum 1997, 9:62.
11. Girschick H.J., Huppertz H.I., Harmsen D., Krauspe R., Müller-Hermelink H.K., et al. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol 1999, 30:59-65.
12. Wagner A.D., Andersen J., Jendro M.C., Hulsemann J.L., Zeidler H. Sustained response to tumor necrosis factor alpha blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002, 46:1965-1968.
13. Jansson A., Renner E.D., Ramser J., Mayer A., Haban M., Meindl A., et al. Classification of non-bacterial osteitis: Retrospective study of clinical, immunological and genetic aspects in 89patients. Rheumatology (Oxford) 2007, 46:154-160.
14. Colina M., Govoni M., Orzincolo C., Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71subjects. Arthritis Rheum 2009, 61:813-821.
15. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
16. Hurtado-Nedelec M., Chollet-Martin S., Chapeton D., Hugot J.P., Hayem G., Gérard B. Genetic susceptibility factors in a cohort of 38patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2genes. J Rheumatol 2010, 37:401-409.
17. Assmann G., Wagner A.D., Monika M., Pfoehler C., Pfreundschuh M., Tilgen W., et al. Single-nucleotide polymorphisms p53G72C and Mdm2T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 2010, 30:1273-1276.
18. Golla A., Jansson A., Ramser J., Hellebrand H., Zahn R., Meitinger T., et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 2002, 10:217-221.
19. Claude P., Clerk D., Cariou D., Lavabre C., Veneucie P.Y., Bissob M. SAPHO syndrome and pyoderma gangrenosum: is it fortuitous. J Rheumatol 1996, 23:400-402.
20. Edwards T.C., Stapleton B., Bond M.J., Barrett F.F. Sweet's syndrome with multifocal sterile osteomyelitis. Am J Dis Child 1986, 140:817-818.
21. DiMeco F., Clatterbuck R.E., Li K.W., McCarthy E.F., Olivi A. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome presenting as a primary calvarial lesion. Case report and review of the literature. J Neurosurg 2000, 93:693-697.
22. Kawai K., Doita M., Tateishi H., Hirohata K. Bone and joint lesions associated with pustulosis palmaris and plantaris. J Bone Joint Surg 1988, 70:117-122.
23. Edlund E., Johnsson U., Lidgren L., Pettersson H., Sturfeld G., Svensson B., et al. Palmoplantar pustulosis and sternoclavicular arthro-osteitis. Ann Rheum Dis 1988, 47:809-815.
24. Aubry-Rozier B., Basch A., Dudler J. Ostéomyélite sclérosante diffuse de la mandibule et SAPHO. Rev Med Interne 2012, 33:e34-e37.
25. Deltombe T., Nisolle J.F., Boutsen Y., Gustin T., Gilliard C., Hanson P. Cervical spinal cord injury in SAPHO syndrome. Spinal Cord 1999, 37:301-304.
26. Collange C., Brantus J.F., Sidot C., Meunier P.J. Sapho syndrome with femoral hyperostosis. Two case-reports. Rev Rhum 1996, 63:367-370.
27. Toussirot E., Dupond J.L., Wendling D. Spondylodiscitis in SAPHO syndrome. A series of eight cases. Ann Rheum Dis 1997, 56:52-58.
28. Rosner I.A., Burg C.G., Wisnieski J.J., Schacter B.Z., Richter D.E. The clinical spectrum of the arthropathy associated with hidrosadenitis suppurativa and acne conglobata. J Rheumatol 1993, 20:684-687.
29. Laasonen L.S., Karvonen S.L., Reunala T.L. Bone disease in adolescents with acne fulminans and severe cystic acne: radiologic and scintigraphic findings. AJR Am J Roentgenol 1994, 162:1161-1165.
30. Özyemisci-Taskiran O., Bölükbasi N., Gögüs F. A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria. Clin Rheumatol 2007, 26:789-791.
31. Steinhoff J.P., Cilursu A., Falasca G.F., Guzman L., Reginato A.J. A study of musculoskeletal manifestations in 12patients with SAPHO syndrome. J Clin Rheumatol 2002, 8:13-22.
32. Smith M., Buller A., Radford R., Laitt R., Leatherbarrow B. Ocular presentation of the SAPHO syndrome. Br J Ophthalmol 2005, 89:1069-1070.
33. Coloe J., Diamantis S., Henderson F., Morrell D.S. Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year-old patient. J Am Acad Dermatol 2010, 62:333-336.
34. Fritz J., Tzaribatchev N., Claussen C.D., Carrino J.A., Horger M.S. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology 2009, 252:842-851.
35. Depasquale R., Kumar N., Lalam R.K., Tins B.J., Tyrell P.N., Singh J., et al. SAPHO: what radiologists should know. Clin Radiol 2012, 67:195-206.
36. Parlier-Cuau C., Laredo J.D. Atteinte vertébrale du SAPHO. J Radiol 2010, 91:1068-1078.
37. Cabay J.E., Marcelis S., Dondelinger K.F. La spondilodiscite inflammatoire comme manifestation radiologique unique du SAPHO. J Radiol 1998, 79:337-340.
38. Kahn M.F., Bouchon J.P., Chamot A.M., Palazzo E. Entérocolopathies chroniques et syndrome SAPHO: 8observations. Rev Rhum Mal Osteoartic 1992, 59:91-94.
39. Shilling F., Marker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: enteropathic CRMO. Z Rheumatol 2003, 62:527-538.
40. Pons J.C., Nekhlyudov L., Delfraissy J.F. The course of the SAPHO syndrome during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996, 70:215-216.
41. Ha D.E., Revaux A., Ait Hammou F., Westerman M.N., Colau J.C. Grossesse chez une patiente présentant un syndrome de SAPHO. Gynecol Obstet (Paris) 2006, 34:1151-1153.
42. Catalano-Pons C., Comte A., Wipff J., Quartier P., Faye A., Gendrel D., et al. Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford) 2008, 47:1397-1399.
43. Wipff J., Adamsbaum C., Kahan A., Job-Deslandre C. Chronic recurrent multifocalosteomyelitis. Joint Bone Spine 2011, 78:555-560.
44. Huber A.M., Lam P.Y., Duffy C.M., Yeung R.S., Ditchfield M., Laxer D., et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr 2002, 141:198-203.
45. Hayem G., Bouchaud-Chabot A., Benali K., Roux S., Palazzo E., Silberman-Hoffman O., et al. SAPHO syndrome: a long-term follow-up study of 120cases. Semin Arthritis Rheum 1999, 29:159-171.
46. Rozin A.P., Nahir A.M. Is SAPHO syndrome a target for antibiotic therapy?. Clin Rheumatol 2007, 26:817-820.
47. Amital H., Applbaum Y.H., Aamar S., Daniel N., Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10patients. Rheumatology 2004, 43:658-661.
48. Ichikawa J., Sato E., Haro H., Ando T., Maekawa S., Hamada Y. Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int 2009, 29:713-715.
49. Moll C., Hernández M.V., Cañete J.D., Gómez-Puerta J.A., Soriano A., Collado A., et al. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum 2008, 37:299-306.
50. Iqbal M., Kolodney M.S. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 2005, 52:118-120.
51. Fruehauf J., Cierny-Modrè B., Caelen Lel S., Schwarz T., Weinke R., et al. Response to infliximab in SAPHO syndrome. Br Med J 2009, 1:1145.
52. Vilar-Alejo J., Dehesa L., de la Rosa-del Rey P., Novoa-Medina J., Valeron-Almazan P., Santana Medina N., et al. SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept. Acta Derm Venereol 2010, 90:531-532.
53. Arias-Santiago S., Sanchez-Cano D., Callejas-Rubio J.L., Fernández-Pugnaire M.A. Adalimumab treatment for SAPHO syndrome. Acta Derm Venereol 2010, 90:301-302.